Status:

COMPLETED

TMS Augmented Exposure Therapy

Lead Sponsor:

Wuerzburg University Hospital

Conditions:

Phobia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realize...

Eligibility Criteria

Inclusion

  • Criteria for a simple phobia: specific heights

Exclusion

  • Objective tinnitus Involvement in psychiatric treatments Clinically relevant psychiatric comorbidity Clinically relevant unstable internal or neurological comorbidity History of or evidence of significant brain malformation or neoplasm, head injury Cerebral vascular events Neurodegenerative disorder affecting the brain or prior brain surgery Metal objects in and around body that can not be removed Pregnancy Alcohol or drug abuse history of seizures

Key Trial Info

Start Date :

August 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT02223767

Start Date

August 1 2014

End Date

October 1 2015

Last Update

August 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University hospital

Würzburg, Germany, 97080

TMS Augmented Exposure Therapy | DecenTrialz